MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-18-2026
QIAGEN N.V. P/S Ratio 2011-2026 | QGEN
Annual P/S Ratio QIAGEN N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 5.03 | 6.11 | 5.33 | 5.8 | 5.42 | 4.81 | 4.13 | 3.96 | 3.99 | 3.97 | 3.27 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.11 | 3.27 | 4.71 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.11 | $ 206.11 | 0.77 % | $ 22.9 B | USA |
 |
Fulgent Genetics
FLGT
|
1.63 | $ 19.0 | 2.7 % | $ 585 M | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
9.4 | $ 4.16 | -7.56 % | $ 5.53 M | USA |
 |
Castle Biosciences
CSTL
|
1.37 | $ 21.22 | 0.66 % | $ 615 M | USA |
 |
Aspira Women's Health
AWH
|
0.37 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.316 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
13.7 | $ 131.65 | 1.18 % | $ 16.5 B | USA |
 |
CareDx, Inc
CDNA
|
2.61 | $ 22.89 | 0.62 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
1.23 | $ 150.72 | -0.73 % | $ 11.8 B |  Irlanda |
 |
Illumina
ILMN
|
5.82 | $ 165.92 | 3.68 % | $ 25.7 B | USA |
 |
Interpace Biosciences
IDXG
|
0.19 | $ 1.79 | 2.87 % | $ 7.92 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.244 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
19.5 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
0.62 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 101.92 | 1.94 % | $ 6.88 B | USA |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 190.0 | 0.08 % | $ 9.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 472.58 | 1.24 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
7.06 | $ 1 142.7 | -1.74 % | $ 23.6 B |  Schweiz |
 |
NeoGenomics
NEO
|
2.04 | $ 11.69 | 2.19 % | $ 1.5 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.61 | 1.54 % | $ 427 M | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 21.13 | 6.99 % | $ 473 M | USA |
 |
Natera
NTRA
|
13.2 | $ 217.87 | -2.22 % | $ 29.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
3.11 | $ 1.39 | 1.47 % | $ 417 M | USA |
 |
Personalis
PSNL
|
6.19 | $ 10.01 | 2.62 % | $ 893 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.7 | $ 25.86 | -2.42 % | $ 24.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
9.94 | $ 7.37 | -0.81 % | $ 308 M | USA |
 |
Soleno Therapeutics
SLNO
|
10.9 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.03 | -1.02 % | $ 4.66 M | USA |
 |
Twist Bioscience Corporation
TWST
|
4.15 | $ 68.85 | -1.73 % | $ 4.12 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 273.95 | 1.01 % | $ 22.8 B | USA |
 |
Waters Corporation
WAT
|
21.1 | $ 369.51 | -0.44 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 488.1 | -1.21 % | $ 184 B | USA |
 |
Trinity Biotech plc
TRIB
|
3.15 | $ 0.68 | 1.91 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
1.14 | $ 9.24 | -0.48 % | $ 2 B | USA |